{"id":"https://openalex.org/W2557308131","doi":"https://doi.org/10.1182/blood.v108.11.880.880","title":"Once-Daily Enoxaparin for the Treatment of Pediatric Thromboembolic Disease \u2014 A Pilot Study.","display_name":"Once-Daily Enoxaparin for the Treatment of Pediatric Thromboembolic Disease \u2014 A Pilot Study.","publication_year":2006,"publication_date":"2006-11-16","ids":{"openalex":"https://openalex.org/W2557308131","doi":"https://doi.org/10.1182/blood.v108.11.880.880","mag":"2557308131"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v108.11.880.880","doi":"https://doi.org/10.1182/blood.v108.11.880.880","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v108.11.880.880","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050829820","display_name":"Sarah H. O\u2019Brien","orcid":"https://orcid.org/0000-0001-8855-9746","observed_orcids":["https://orcid.org/0000-0001-8855-9746","https://orcid.org/0000-0001-9939-6292"]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah O\u2019Brien","raw_affiliation_strings":["Pediatric Hematology/Oncology, Columbus Children\u2019s Hospital, Columbus, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Hematology/Oncology, Columbus Children\u2019s Hospital, Columbus, OH, USA","institution_ids":["https://openalex.org/I1314135232"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034383757","display_name":"Arthur Kim Ritchey","orcid":"https://orcid.org/0000-0002-2750-7536","observed_orcids":["https://orcid.org/0000-0002-2750-7536"]},"institutions":[{"id":"https://openalex.org/I4210130600","display_name":"Children's Hospital of Pittsburgh","ror":"https://ror.org/03763ep67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210130600","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arthur K. Ritchey","raw_affiliation_strings":["Pediatric Hematology/Oncology, Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Hematology/Oncology, Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I4210130600"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.42168238,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"108","issue":"11","first_page":"880","last_page":"880"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enoxaparin","display_name":"enoxaparin","score":0.9049999713897705},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.9660000205039978},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9700000286102295},{"id":"https://openalex.org/keywords/anti-xa-levels","display_name":"anti-Xa levels","score":0.7490000128746033},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9139999747276306},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.6779999732971191},{"id":"https://openalex.org/keywords/heparin-clearance","display_name":"heparin clearance","score":0.7070000171661377},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.7239999771118164},{"id":"https://openalex.org/keywords/thromboprophylaxis","display_name":"thromboprophylaxis","score":0.7200000286102295},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.3720000088214874},{"id":"https://openalex.org/keywords/anticoagulation-safety","display_name":"anticoagulant safety","score":0.574999988079071},{"id":"https://openalex.org/keywords/bleeding-complications","display_name":"bleeding complications","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8799222707748413},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7946279048919678},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5757764577865601},{"id":"https://openalex.org/C34626388","wikidata":"https://www.wikidata.org/wiki/Q721129","display_name":"Nomogram","level":2,"score":0.5108699202537537},{"id":"https://openalex.org/C2778825682","wikidata":"https://www.wikidata.org/wiki/Q416516","display_name":"Enoxaparin sodium","level":4,"score":0.44665923714637756},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.42641839385032654},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3658254146575928},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.3537008762359619},{"id":"https://openalex.org/C2776884760","wikidata":"https://www.wikidata.org/wiki/Q2750727","display_name":"Low molecular weight heparin","level":3,"score":0.35318154096603394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2557230293750763}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v108.11.880.880","doi":"https://doi.org/10.1182/blood.v108.11.880.880","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v108.11.880.880","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1569239833","https://openalex.org/W4394581170","https://openalex.org/W3102640490","https://openalex.org/W4388702000","https://openalex.org/W2043765279","https://openalex.org/W2528532635","https://openalex.org/W2108043885","https://openalex.org/W7202098278","https://openalex.org/W1836988500","https://openalex.org/W4409181143"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"&":[2],"Aim:":[3],"The":[4,336],"current":[5],"recommended":[6,153],"starting":[7,338],"dose":[8,132,206,339,374],"of":[9,43,83,133,158,171,200,207,234,246,316,325,340],"enoxaparin":[10,30,61,85,118,162,327,342,370],"in":[11,19,37,50,86,261,328,343],"children":[12,202,236],"is":[13,347],"1":[14,384,434,443,468,477,486],"mg/kg/dose":[15],"administered":[16,119],"twice-daily.":[17],"Studies":[18],"adults,":[20],"however,":[21],"have":[22,267,279],"demonstrated":[23],"similar":[24],"safety":[25,94],"and":[26,33,40,55,88,95,191,244,274],"efficacy":[27],"between":[28,53,149],"once-daily":[29,60,84,161,326,341],"(1.5":[31],"mg/kg/dose)":[32,36],"twice-daily":[34],"(1":[35],"the":[38,81,130,155,197,227,298,329],"initial":[39],"long-term":[41],"treatment":[42],"venous":[44,378,382],"thromboembolism.":[45],"Due":[46],"to":[47,74,79,89,103,140,144,210,334,356],"known":[48],"differences":[49],"heparin":[51],"clearance":[52,324],"adults":[54],"young":[56,344],"children,":[57,87],"recommendations":[58],"for":[59,160,369],"dosing":[62],"should":[63],"not":[64],"simply":[65],"be":[66],"extrapolated":[67],"from":[68,258,297],"adult":[69,259],"literature.":[70],"Our":[71,319],"objective":[72],"was":[73,295,305],"perform":[75],"a":[76,141,169,204,309],"pilot":[77,320],"study":[78,142,299],"describe":[80],"pharmacodynamics":[82],"gather":[90],"preliminary":[91],"data":[92,321],"regarding":[93],"feasibility.":[96],"Methods:":[97],"15":[98,221,471,480,489],"patients,":[99],"ages":[100],"3":[101,385,402,421,502],"months":[102,386,395,404],"16":[104,498],"years,":[105],"with":[106,115,179,226,389,398,407,416,432,450,459,475,493],"newly":[107],"diagnosed":[108],"thromboembolism":[109],"were":[110,125,137,167,286],"enrolled.":[111],"All":[112],"began":[113],"therapy":[114],"1.5":[116,351,496],"mg/kg":[117,209],"once-daily.":[120],"Initial":[121],"peak":[122,146,213,359],"anti-Xa":[123,147,180,214,239,360],"levels":[124,148,166,181,215,225,240,250,264,276],"drawn":[126,182],"4\u20136":[127],"hours":[128,271],"after":[129,272,308],"second":[131],"enoxaparin.":[134],"Dose":[135,353,371],"adjustments":[136,354],"made":[138],"according":[139],"nomogram":[143],"achieve":[145,211,357],"1\u20132":[150],"U/ml,":[151],"as":[152,332],"by":[154,241,251],"American":[156],"College":[157],"Pathologists":[159],"dosing.":[163],"Once":[164],"therapeutic":[165,263],"achieved,":[168],"subgroup":[170],"8":[172,199,235,247,428,445],"patients":[173,195,346],"underwent":[174],"24\u2013hour":[175],"pharmacodynamic":[176],"(PD)":[177],"monitoring,":[178],"at":[183,282,314],"Hours":[184],"0,":[185],"2,":[186],"4,":[187],"8,":[188],"12,":[189,243],"18,":[190],"24.":[192],"Results:":[193],"14":[194,201,403,414,423,455,464,497],"completed":[196],"study.":[198],"required":[203],"final":[205],">2":[208],"target":[212,224,358],"(Table).":[216],"Only":[217],"one":[218],"participant":[219],"(age":[220],"years)":[222],"achieved":[223],"original":[228],"dose.":[229],"In":[230],"PD":[231],"studies,":[232],"7":[233,436],"had":[237,248],"subtherapeutic":[238],"Hour":[242,252],"4":[245,391,400,401,411,418],"unmeasurable":[249],"18":[253],"(Figure).":[254],"These":[255],"results":[256],"differ":[257],"studies":[260],"which":[262],"(0.5\u20131.0":[265],"U/ml)":[266,278],"been":[268,280],"measurable":[269,281],"13\u201318":[270],"administration,":[273],"prophylactic":[275],"(0.1\u20130.3":[277],"24":[283],"hours.":[284],"There":[285],"no":[287],"new":[288],"or":[289],"recurrent":[290],"thrombotic":[291],"events.":[292],"One":[293],"patient":[294],"removed":[296],"on":[300],"Day":[301],"2":[302,393,409,412,425,452,461],"because":[303],"anticoagulation":[304],"permanently":[306],"discontinued":[307],"post-surgical":[310],"bleed":[311],"(anti-Xa":[312],"0.23":[313],"time":[315],"event).":[317],"Conclusion:":[318],"suggests":[322],"faster":[323],"pediatric":[330,345],"population":[331],"compared":[333],"adults.":[335],"appropriate":[337],"likely":[348],"higher":[349],"than":[350],"mg/kg.":[352],"needed":[355],"activity":[361],"(1\u20132":[362],"IU/ml)":[363],"Patient":[364],"Age":[365],"Weight":[366],"(kg)":[367],"Indication":[368],"changes":[372],"Final":[373],"(mg/kg)":[375],"DVT,":[376],"deep":[377],"thrombosis;":[379],"CVL,":[380],"central":[381],"line":[383],"6.5":[387],"DVT":[388,397,406,415,424,431,449,458,467,474,492,501],"CVL":[390,399,408,417,433,451,460,476,494],"3.8":[392],"10":[394,396,463],"13":[405,446,488],"2.3":[410],"years":[413,422,429,438,447,456,465,472,481,490,499],"2.7":[419,426],"5":[420],"6":[427],"83":[430],"1.7":[435],"9":[437,454],"37":[439],"Arterial":[440,483],"ischemic":[441,484],"stroke":[442,485],"1.9":[444,478],"67":[448],"2.1":[453],"65":[457],"2.2":[462],"68":[466],"1.8":[469],"11":[470],"60":[473,482],"12":[479],"1.6":[487],"77":[491],"0":[495],"45":[500],"2.9":[503],"Figure":[504,505]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-12-08T00:00:00"}